Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT2 | O15382 | 1/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2534154 | 0.87 | CA2 (0.32) | BCAT2KEAP1 | |
| SCHEMBL11548155 | 0.81 | CA2 (0.50) | — | |
| SCHEMBL7764280 | 0.81 | ELANE (0.36) | — | |
| SCHEMBL1804225 | 0.81 | TTR (0.43) | CYP1A2 | |
| SCHEMBL18207235 | 0.80 | PTGS1 (0.37) | — | |
| SCHEMBL8651626 | 0.80 | — | — | |
| SCHEMBL7475023 | 0.78 | HTR6 (0.45) | — | |
| SCHEMBL17288500 | 0.77 | MEN1 (0.30) | — | |
| SCHEMBL26092150 | 0.73 | MCL1 (0.48) | KEAP1 | |
| SCHEMBL250357 | 0.73 | KEAP1 (0.54) | KEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090318720-A1 | Process for selectively synthesising 3 alpha-hydroxychlormadinone acetate | GRUNENTHAL GMBH (DE) | 2009-12-24 | — | — | US | disclosed |
| WO-2009141110-A1 | METHOD FOR THE SELECTIVE SYNTHESIS OF 3-ALPHA-HYDROXY-CHLORMADINONE ACETATE | Grünenthal GmbH (DE) | 2009-11-26 | — | — | WO | disclosed |
| EP-0866367-A2 | Radiation sensitive composition | JSR Corporation (JP) | 1998-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318720-A1 | Process for selectively synthesising 3 alpha-hydroxychlormadinone acetate | CYP51A1, HSD17B7, HSD17B13 | BCAT2 697/4885KEAP1 518/4885CYP1A2 52/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.